Hu H - Search Results

1

Reduction-Responsive RGD-Docetaxel Conjugate: Synthesis, In Vitro Drug Release and In Vitro Antitumor Activity.

Li Q, Liu Y, Cheng Y, Cao H, Du K, Zhu T, Xu D, Hu H. Li Q, et al. Among authors: hu h. Drug Dev Res. 2025 Feb;86(1):e70043. doi: 10.1002/ddr.70043. Drug Dev Res. 2025. PMID: 39722470

2

A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers.

Cui X, Du K, Yuan X, Xiao W, Tao Y, Xu D, Hu H. Cui X, et al. Among authors: hu h. Drug Dev Res. 2022 May;83(3):646-658. doi: 10.1002/ddr.21896. Epub 2021 Nov 3. Drug Dev Res. 2022. PMID: 34730851

3

Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells.

Yuan X, Tao Y, Xiao W, Du K, Hu H, Xu D, Xu Q. Yuan X, et al. Among authors: hu h. Drug Dev Res. 2022 Dec;83(8):1923-1933. doi: 10.1002/ddr.22007. Epub 2022 Oct 27. Drug Dev Res. 2022. PMID: 36301989

4

Synthesis and in vitro antitumor activity of galactosamine-docetaxel conjugates.

Shen Y, Cheng Y, Hu H, Liu Y, Li Y, Zhu T, Xu D, Hu H. Shen Y, et al. Among authors: hu h. Chem Biol Drug Des. 2024 Mar;103(3):e14511. doi: 10.1111/cbdd.14511. Chem Biol Drug Des. 2024. PMID: 38508859

5

iRGD-paclitaxel conjugate nanoparticles for targeted paclitaxel delivery.

Hu H, Wang B, Lai C, Xu X, Zhen Z, Zhou H, Xu D. Hu H, et al. Drug Dev Res. 2019 Dec;80(8):1080-1088. doi: 10.1002/ddr.21589. Epub 2019 Aug 14. Drug Dev Res. 2019. PMID: 31411346

6

Hydroxyethyl starch-new indocyanine green conjugates for enhanced cancer photodynamic therapy.

He X, Hong J, Liu S, Xu D, Hu H. He X, et al. Among authors: hu h. Carbohydr Res. 2021 Oct;508:108416. doi: 10.1016/j.carres.2021.108416. Epub 2021 Jul 31. Carbohydr Res. 2021. PMID: 34352650

7

Biotin-new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution.

Liu S, Ding F, Xu W, Miu L, Tang Y, Xu D, Zhu T, Hu H. Liu S, et al. Among authors: hu h. Chem Biol Drug Des. 2024 Mar;103(3):e14495. doi: 10.1111/cbdd.14495. Chem Biol Drug Des. 2024. PMID: 38444045

8

Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy.

Liu J, Ni Y, Zhou K, Wu G, Hu L, Zhu T, Xu D, Hu H. Liu J, et al. Among authors: hu h, hu l. Chem Biol Drug Des. 2024 Jul;104(1):e14583. doi: 10.1111/cbdd.14583. Chem Biol Drug Des. 2024. PMID: 38991995

9

Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer.

Xu D, Hu H, Guan J, Da J, Xie Y, Liu Y, Kong R, Song G, Zhou H. Xu D, et al. Among authors: hu h. Chem Biol Drug Des. 2019 Sep;94(3):1656-1663. doi: 10.1111/cbdd.13567. Epub 2019 Jun 19. Chem Biol Drug Des. 2019. PMID: 31108007

10

Reduction-responsive worm-like nanoparticles for synergistic cancer chemo-photodynamic therapy.

Hu H, Xu D, Xu Q, Tang Y, Hong J, Hu Y, Wang J, Ni X. Hu H, et al. Among authors: hu y. Mater Today Bio. 2023 Jan 4;18:100542. doi: 10.1016/j.mtbio.2023.100542. eCollection 2023 Feb. Mater Today Bio. 2023. PMID: 36647538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,290 results

Search Page

Filters